Trial Profile
Tolerability, pharmacokinetics and pharmacodynamics of etamicastat administered as multiple escalating doses in male patients with hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Jan 2014
Price :
$35
*
At a glance
- Drugs Etamicastat (Primary)
- Indications Essential hypertension
- Focus Adverse reactions; Pharmacodynamics; Pharmacogenomic; Pharmacokinetics
- Sponsors Bial
- 12 Jan 2014 New trial record
- 29 Nov 2013 Results published in Clinical Therapeutics.